Shenda Hou

478 total citations
8 papers, 233 citations indexed

About

Shenda Hou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shenda Hou has authored 8 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shenda Hou's work include Cancer Genomics and Diagnostics (2 papers), Immune Cell Function and Interaction (2 papers) and Lung Cancer Research Studies (2 papers). Shenda Hou is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Immune Cell Function and Interaction (2 papers) and Lung Cancer Research Studies (2 papers). Shenda Hou collaborates with scholars based in China and United States. Shenda Hou's co-authors include Hongbin Ji, Xiangkun Han, Rachel L. Clement, Alexander Y. Rudensky, Arlene H. Sharpe, Peter T. Sage, Alos Diallo, Bruce R. Blazar, Shun Yao and Yang Liu and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cancer Research.

In The Last Decade

Shenda Hou

8 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenda Hou China 6 104 63 56 56 47 8 233
Xiaowei Xi China 8 202 1.9× 50 0.8× 33 0.6× 41 0.7× 18 0.4× 12 264
Sophie Léon France 4 92 0.9× 54 0.9× 23 0.4× 64 1.1× 21 0.4× 4 167
Ellen S. Hong United States 6 121 1.2× 18 0.3× 67 1.2× 77 1.4× 29 0.6× 11 219
Guinevere Chun United States 6 146 1.4× 56 0.9× 74 1.3× 134 2.4× 17 0.4× 20 265
Yueli Shi China 10 188 1.8× 75 1.2× 62 1.1× 81 1.4× 20 0.4× 23 303
Chunfang Ha China 9 160 1.5× 49 0.8× 23 0.4× 76 1.4× 29 0.6× 25 308
Laura Esteban-Burgos Spain 7 159 1.5× 80 1.3× 41 0.7× 71 1.3× 21 0.4× 7 273
Melissa Pool Pizzi United States 9 134 1.3× 30 0.5× 38 0.7× 46 0.8× 26 0.6× 19 208

Countries citing papers authored by Shenda Hou

Since Specialization
Citations

This map shows the geographic impact of Shenda Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenda Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenda Hou more than expected).

Fields of papers citing papers by Shenda Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenda Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenda Hou. The network helps show where Shenda Hou may publish in the future.

Co-authorship network of co-authors of Shenda Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Shenda Hou. A scholar is included among the top collaborators of Shenda Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenda Hou. Shenda Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Calderón‐Colón, Xiomara, et al.. (2022). Design and characterization of lipid nanocarriers for oral delivery of immunotherapeutic peptides. Journal of Biomedical Materials Research Part A. 111(7). 938–949. 8 indexed citations
2.
Raimondi, Giorgio, et al.. (2022). Prevention of Type 1 Diabetes via a Lipid Nanoparticle-Based Oral Immunotherapy that Targets Selective Lymphoid Tissues. The Journal of Immunology. 208(Supplement_1). 174.12–174.12. 1 indexed citations
3.
Hou, Shenda, Rachel L. Clement, Alos Diallo, et al.. (2019). FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program. The Journal of Experimental Medicine. 216(3). 605–620. 65 indexed citations
4.
Huang, Hsin‐Yi, Wenjing Zhang, Yijun Gao, et al.. (2017). YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation. Cancer Research. 77(21). 5769–5781. 68 indexed citations
5.
Hou, Shenda, Zhen Qin, Yang Liu, et al.. (2017). Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma. American Journal Of Pathology. 187(5). 954–962. 45 indexed citations
6.
Hou, Shenda, et al.. (2016). Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance. Protein & Cell. 8(3). 178–190. 26 indexed citations
7.
Hou, Shenda, Xiangkun Han, & Hongbin Ji. (2016). Squamous Transition of Lung Adenocarcinoma and Drug Resistance. Trends in cancer. 2(9). 463–466. 18 indexed citations
8.
Lin, Hongli, et al.. (2014). [Immunogenicity of recombinant Lactobacillus casei expressing VP2 protein of infectious bursal disease virus in chickens].. PubMed. 30(11). 1679–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026